Canada markets closed

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.44-0.41 (-5.99%)
At close: 04:00PM EST
6.38 -0.06 (-0.93%)
After hours: 04:38PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close6.85
Open6.79
Bid6.43 x 800
Ask6.62 x 900
Day's Range6.38 - 6.87
52 Week Range3.55 - 9.59
Volume133,525
Avg. Volume201,783
Market Cap382.682M
Beta (5Y Monthly)1.85
PE Ratio (TTM)N/A
EPS (TTM)-2.27
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.00
  • GlobeNewswire

    Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th at 4:30 p.m. PST in San Francisco, CA. A live webcast of the company presentation will be available on the investor section of the company website at investors.generationbio.com. About Generation Bio

  • Zacks

    Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect?

    The average of price targets set by Wall Street analysts indicates a potential upside of 183.8% in Generation Bio Co. (GBIO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Zacks

    Wall Street Analysts Think Generation Bio Co. (GBIO) Could Surge 176%: Read This Before Placing a Bet

    The consensus price target hints at a 176% upside potential for Generation Bio Co. (GBIO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.